GW Pharmaceuticals stock collapsed after the biotech company reported $91 million in sales for its third quarter ended Sept. 30. That beat expectations for $87 million in quarterly sales. Read More...
Shares Of This CBD Oil-Selling Biotech Crashed Despite Quarterly Beat
GW Pharmaceuticals stock collapsed after the biotech company reported $91 million in sales for its third quarter ended Sept. 30. That beat expectations for $87 million in quarterly sales.
